To evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) in reducing movement-evoked pain in patients with fibromyalgia when added to routine physical therapy.
Key Findings:
Movement-evoked pain decreased more in the TENS group compared to the control group at 60 days, with a mean difference of 1.2 points on a 0 to 10 scale.
41% of TENS patients achieved at least a 30% reduction in movement-evoked pain versus 13% in the control group.
72% of TENS patients reported improvement on the Patient Global Impression of Change compared to 51% in the control group.
Secondary outcomes favored TENS, showing significant reductions in resting pain, fatigue, and overall disease impact.
No serious adverse events related to TENS were reported; minor adverse events occurred in about 30% of patients.
Interpretation:
TENS provides small to moderate improvements in pain and related symptoms in fibromyalgia patients, supporting its use as a nonpharmacologic treatment option.
Limitations:
Variability in physical therapy approaches, which were not standardized or tailored to fibromyalgia.
Inability to assess changes in medication use.
Underrepresentation of racial and ethnic minority populations.
Conclusion:
TENS produced effects quickly and remained effective through six months, representing a safe treatment option for fibromyalgia.